Literature DB >> 21403089

Cardiovascular outcomes in framingham participants with diabetes: the importance of blood pressure.

Guanmin Chen1, Finlay A McAlister, Robin L Walker, Brenda R Hemmelgarn, Norm R C Campbell.   

Abstract

We designed this study to explore to what extent the excess risk of cardiovascular events in diabetic individuals is attributable to hypertension. We retrospectively analyzed prospectively collected data from the Framingham original and offspring cohorts. Of the 1145 Framingham subjects newly diagnosed with diabetes mellitus who did not have a previous history of cardiovascular events, 663 (58%) had hypertension at the time that diabetes mellitus was diagnosed. During 4154 person-years of follow-up, 125 died, and 204 experienced a cardiovascular event. Framingham participants with hypertension at the time of diabetes mellitus diagnosis exhibited higher rates of all-cause mortality (32 versus 20 per 1000 person-years; P<0.001) and cardiovascular events (52 versus 31 per 1000 person-years; P<0.001) compared with normotensive subjects with diabetes mellitus. After adjustment for demographic and clinical covariates, hypertension was associated with a 72% increase in the risk of all-cause death and a 57% increase in the risk of any cardiovascular event in individuals with diabetes mellitus. The population-attributable risk from hypertension in individuals with diabetes mellitus was 30% for all-cause death and 25% for any cardiovascular event (increasing to 44% and 41%, respectively, if the 110 normotensive subjects who developed hypertension during follow-up were excluded from the analysis). In comparison, after adjustment for concurrent hypertension, the population-attributable risk from diabetes mellitus in Framingham subjects was 7% for all-cause mortality and 9% for any cardiovascular disease event. Although diabetes mellitus is associated with increased risks of death and cardiovascular events in Framingham subjects, much of this excess risk is attributable to coexistent hypertension.

Entities:  

Mesh:

Year:  2011        PMID: 21403089      PMCID: PMC3785072          DOI: 10.1161/HYPERTENSIONAHA.110.162446

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  24 in total

1.  Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study.

Authors:  Craig J Currie; John R Peters; Aodán Tynan; Marc Evans; Robert J Heine; Oswaldo L Bracco; Tony Zagar; Chris D Poole
Journal:  Lancet       Date:  2010-01-26       Impact factor: 79.321

2.  Effects of intensive blood-pressure control in type 2 diabetes mellitus.

Authors:  William C Cushman; Gregory W Evans; Robert P Byington; David C Goff; Richard H Grimm; Jeffrey A Cutler; Denise G Simons-Morton; Jan N Basile; Marshall A Corson; Jeffrey L Probstfield; Lois Katz; Kevin A Peterson; William T Friedewald; John B Buse; J Thomas Bigger; Hertzel C Gerstein; Faramarz Ismail-Beigi
Journal:  N Engl J Med       Date:  2010-03-14       Impact factor: 91.245

3.  Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes.

Authors: 
Journal:  JAMA       Date:  2002-05-15       Impact factor: 56.272

4.  Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.

Authors:  Anushka Patel; S MacMahon; J Chalmers; B Neal; M Woodward; L Billot; S Harrap; N Poulter; M Marre; M Cooper; P Glasziou; D E Grobbee; P Hamet; S Heller; L S Liu; G Mancia; C E Mogensen; C Y Pan; A Rodgers; B Williams
Journal:  Lancet       Date:  2007-09-08       Impact factor: 79.321

5.  Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies.

Authors:  N Sarwar; P Gao; S R Kondapally Seshasai; R Gobin; S Kaptoge; E Di Angelantonio; E Ingelsson; D A Lawlor; E Selvin; M Stampfer; C D A Stehouwer; S Lewington; L Pennells; A Thompson; N Sattar; I R White; K K Ray; J Danesh
Journal:  Lancet       Date:  2010-06-26       Impact factor: 202.731

6.  Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study.

Authors:  Xin Du; Toshiharu Ninomiya; Bastiaan de Galan; Edward Abadir; John Chalmers; Avinesh Pillai; Mark Woodward; Mark Cooper; Stephen Harrap; Pavel Hamet; Neil Poulter; Gregory Y H Lip; Anushka Patel
Journal:  Eur Heart J       Date:  2009-03-11       Impact factor: 29.983

7.  Long-term follow-up after tight control of blood pressure in type 2 diabetes.

Authors:  Rury R Holman; Sanjoy K Paul; M Angelyn Bethel; H Andrew W Neil; David R Matthews
Journal:  N Engl J Med       Date:  2008-09-10       Impact factor: 91.245

8.  Diabetes in treated hypertension is common and carries a high cardiovascular risk: results from a 28-year follow-up.

Authors:  Torbjörn Almgren; Lars Wilhelmsen; Ola Samuelsson; Anders Himmelmann; Annika Rosengren; Ove K Andersson
Journal:  J Hypertens       Date:  2007-06       Impact factor: 4.844

9.  Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005.

Authors:  Sarah Rosner Preis; Shih-Jen Hwang; Sean Coady; Michael J Pencina; Ralph B D'Agostino; Peter J Savage; Daniel Levy; Caroline S Fox
Journal:  Circulation       Date:  2009-03-23       Impact factor: 29.690

10.  Recurrence of cardiovascular events in patients with type 2 diabetes: epidemiology and risk factors.

Authors:  Carlo B Giorda; Angelo Avogaro; Marina Maggini; Flavia Lombardo; Edoardo Mannucci; Salvatore Turco; Stefania Spila Alegiani; Roberto Raschetti; Mario Velussi; Ele Ferrannini
Journal:  Diabetes Care       Date:  2008-09-09       Impact factor: 17.152

View more
  93 in total

1.  Hypertension revisited.

Authors:  Norm R C Campbell; Richard E Gilbert; Lawrence A Leiter; Pierre Larochelle; Sheldon Tobe; Arun Chockalingam; Richard Ward; Dorothy Morris; Ross T Tsuyuki; Stewart Harris
Journal:  Can Fam Physician       Date:  2012-06       Impact factor: 3.275

2.  Renoprotective effects of berberine as adjuvant therapy for hypertensive patients with type 2 diabetes mellitus: Evaluation via biochemical markers and color Doppler ultrasonography.

Authors:  Peifeng Dai; Junhua Wang; Lin Lin; Yanyan Zhang; Zhengping Wang
Journal:  Exp Ther Med       Date:  2015-06-22       Impact factor: 2.447

3.  [Therapeutic targets in arterial hypertension and diabetes mellitus. Can medical prevention be harmful?].

Authors:  C Chatzikyrkou; H Haller; J Menne
Journal:  Internist (Berl)       Date:  2012-07       Impact factor: 0.743

Review 4.  Hypertension with diabetes mellitus: significance from an epidemiological perspective for Japanese.

Authors:  Yukako Tatsumi; Takayoshi Ohkubo
Journal:  Hypertens Res       Date:  2017-07-13       Impact factor: 3.872

5.  Prevalence of cognitive impairment no dementia in a rural area of Northern China.

Authors:  Ying Zhang; Zhihong Shi; Mengyuan Liu; Shuai Liu; Wei Yue; Shuling Liu; Lei Xiang; Hui Lu; Ping Liu; Thomas Wisniewski; Jinhuan Wang; Yong Ji
Journal:  Neuroepidemiology       Date:  2014-04-15       Impact factor: 3.282

6.  Trans-biobank analysis with 676,000 individuals elucidates the association of polygenic risk scores of complex traits with human lifespan.

Authors:  Saori Sakaue; Masahiro Kanai; Juha Karjalainen; Masato Akiyama; Mitja Kurki; Nana Matoba; Atsushi Takahashi; Makoto Hirata; Michiaki Kubo; Koichi Matsuda; Yoshinori Murakami; Mark J Daly; Yoichiro Kamatani; Yukinori Okada
Journal:  Nat Med       Date:  2020-03-23       Impact factor: 53.440

7.  Take urgent action diagnosing, treating, and controlling hypertension in older women.

Authors:  Mark Gelfer; Alan Bell; Robert Petrella; Norm R C Campbell; Lyne Cloutier; Patrice Lindsay; Alexander A Leung; Dorothy Morris; Donna McLean; Ross T Tsuyuki; Shelita Dattani; Janusz Kaczorowski
Journal:  Can Fam Physician       Date:  2020-10       Impact factor: 3.275

Review 8.  Type 2 diabetes mellitus and hypertension: an update.

Authors:  Guido Lastra; Sofia Syed; L Romayne Kurukulasuriya; Camila Manrique; James R Sowers
Journal:  Endocrinol Metab Clin North Am       Date:  2013-12-12       Impact factor: 4.741

9.  Does socioeconomic status or acculturation modify the association between ethnicity and hypertension treatment before stroke?

Authors:  Deborah A Levine; Lewis B Morgenstern; Kenneth M Langa; Lesli E Skolarus; Melinda A Smith; Lynda D Lisabeth
Journal:  Stroke       Date:  2013-09-17       Impact factor: 7.914

10.  Diabetes mellitus and vascular disease.

Authors:  James R Sowers
Journal:  Hypertension       Date:  2013-05       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.